Express Scripts Says FTC Tried To Swamp It With Lawsuits

By Nadia Dreid · January 31, 2025, 8:56 PM EST

The Federal Trade Commission was trying to "paint a target on [pharmacy benefit managers'] backs" when it released a report that accused the pharmaceutical middlemen of inflating the cost of drugs,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

Express Scripts, Inc. v. The Federal Trade Commission et al

Case Number

Court

Missouri Eastern

Nature of Suit

Other Statutory Actions

Date Filed

September 17, 2024

Recent Articles By Nadia

February 04, 2025
Fed. Circ. Grapples With Extensions On Reissued Patents
January 27, 2025
Takeda Pushes Meijer Antitrust Suit Into Arbitration
January 14, 2025
Fed. Circ. Judge Asks What's The Rush In Eylea Biosimilar Case
December 10, 2024
Judge Won't Cull EpiPen Antitrust Action Against Mylan
November 19, 2024
DC Circ. Wonders Where To Land On Terrorism Liability Claims
November 07, 2024
Sutter Health Could Face Retrial On Antitrust Claims In March
July 17, 2024
Teladoc Hit With Another Investor Suit Over BetterHelp Woes
July 11, 2024
Pfizer's $50M EpiPen Deal Gets Final OK In Antitrust Suit
June 27, 2024
Judge OKs $10M Deal In Generic Price-Fixing MDL
April 16, 2024
NC Treasurer Backs FTC On Hospital Merger Challenge